Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1974 3
1976 2
1978 1
1979 3
1980 4
1981 8
1982 2
1983 4
1984 3
1985 4
1986 9
1987 6
1988 3
1989 5
1990 6
1991 7
1992 4
1993 3
1994 4
1995 8
1996 4
1997 6
1998 5
1999 4
2000 5
2001 7
2002 4
2003 4
2004 3
2005 4
2006 4
2007 3
2008 3
2009 5
2010 3
2011 5
2012 4
2013 1
2014 1
2016 1
2021 1
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

165 results
Results by year
Filters applied: . Clear all
Page 1
Integrated analysis of somatic mutations and focal copy-number changes identifies key genes and pathways in hepatocellular carcinoma.
Guichard C, Amaddeo G, Imbeaud S, Ladeiro Y, Pelletier L, Maad IB, Calderaro J, Bioulac-Sage P, Letexier M, Degos F, Clément B, Balabaud C, Chevet E, Laurent A, Couchy G, Letouzé E, Calvo F, Zucman-Rossi J. Guichard C, et al. Among authors: degos f. Nat Genet. 2012 May 6;44(6):694-8. doi: 10.1038/ng.2256. Nat Genet. 2012. PMID: 22561517 Free PMC article.
[Hepatitis C infection: Therapeutic strategies].
Diatta T, Chavade D, Degos F, d'Andon A, Guillevin L. Diatta T, et al. Among authors: degos f. Presse Med. 2016 May;45(5):495-508. doi: 10.1016/j.lpm.2016.02.006. Epub 2016 Mar 19. Presse Med. 2016. PMID: 27006245 Review. French.
Hepatitis C and alcohol.
Degos F. Degos F. J Hepatol. 1999;31 Suppl 1:113-8. doi: 10.1016/s0168-8278(99)80386-9. J Hepatol. 1999. PMID: 10622572 Review.
[Cholangiocarcinoma: epidemiology and global management].
Dreyer C, Le Tourneau C, Faivre S, Qian Z, Degos F, Vuillerme MP, Paradis V, Hammel P, Ruszniewski P, Cortes A, Farges O, Belghiti J, Valla D, Raymond E. Dreyer C, et al. Among authors: degos f. Rev Med Interne. 2008 Aug;29(8):642-51. doi: 10.1016/j.revmed.2007.11.010. Epub 2008 Feb 12. Rev Med Interne. 2008. PMID: 18272258 Review. French.
Basket clinical trial design for targeted therapies for cancer: a French National Authority for Health statement for health technology assessment.
Lengliné E, Peron J, Vanier A, Gueyffier F, Kouzan S, Dufour P, Guillot B, Blondon H, Clanet M, Cochat P, Degos F, Chevret S, Grande M, Putzolu J; Transparency Committee of the French National Authority for Health. Lengliné E, et al. Among authors: degos f. Lancet Oncol. 2021 Oct;22(10):e430-e434. doi: 10.1016/S1470-2045(21)00337-5. Lancet Oncol. 2021. PMID: 34592192 Review.
[Hepatitis B vaccine after the 2003 consensus conference].
Degos F. Degos F. Gastroenterol Clin Biol. 2005 Apr;29(4):388-92. doi: 10.1016/s0399-8320(05)80786-9. Gastroenterol Clin Biol. 2005. PMID: 15864200 Free article. Review. French. No abstract available.
Epidemiology of hepatitis C virus in Europe.
Degos F. Degos F. FEMS Microbiol Rev. 1994 Jul;14(3):267-71. doi: 10.1111/j.1574-6976.1994.tb00098.x. FEMS Microbiol Rev. 1994. PMID: 7522025 Review.
165 results